Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
US-12595278-B2 · Apr 7, 2026 · US
This page is not indexed by search engines while we improve data quality.
Visnick Melean patents
Visnick Melean is listed as an inventor on 70 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Visnick Melean |
| Total patents | 70 |
| First publication | Jan 6, 2015 |
| Latest publication | Apr 7, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
US-12545701-B2 · Feb 10, 2026 · US
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
US-2025361263-A1 · Nov 27, 2025 · US
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
US-12344631-B2 · Jul 1, 2025 · US
Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other uses
US-2025188053-A1 · Jun 12, 2025 · US
Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
US-2025059154-A1 · Feb 20, 2025 · US
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
US-12195443-B2 · Jan 14, 2025 · US
Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
US-2024360084-A1 · Oct 31, 2024 · US
Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
US-12060340-B2 · Aug 13, 2024 · US
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
US-2024182507-A1 · Jun 6, 2024 · US
Recent patents
Latest publications not already listed above.
Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
US-11993574-B2 · May 28, 2024 · US
Synthetic ursolic acid derivatives and methods of use thereof
US-2024140986-A1 · May 2, 2024 · US
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
US-11827664-B2 · Nov 28, 2023 · US
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
US-11814338-B2 · Nov 14, 2023 · US
C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
US-2023250130-A1 · Aug 10, 2023 · US
Synthetic triterpenoids with nitrogen-based substituents at c-17 and methods of use thereof
US-2023111914-A1 · Apr 13, 2023 · US
C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
US-11584775-B2 · Feb 21, 2023 · US
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
US-2022281807-A1 · Sep 8, 2022 · US
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US-11406648-B2 · Aug 9, 2022 · US
Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other uses
US-2022135534-A1 · May 5, 2022 · US
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
US-11292781-B2 · Apr 5, 2022 · US
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
US-2022024862-A1 · Jan 27, 2022 · US
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
US-11192852-B2 · Dec 7, 2021 · US
Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
US-2021292281-A1 · Sep 23, 2021 · US
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
US-2021261592-A1 · Aug 26, 2021 · US
Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
US-11091430-B2 · Aug 17, 2021 · US
Imidazolyl tricyclic enones as antioxidant inflammation modulators
US-11059792-B2 · Jul 13, 2021 · US
Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
US-2021147380-A1 · May 20, 2021 · US
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US-2021137947-A1 · May 13, 2021 · US
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
US-2021040142-A1 · Feb 11, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Reata Pharmaceuticals Inc | 70 |
| Anderson Eric | 2 |
| Jiang Xin | 2 |
| Visnick Melean | 2 |
| Abbvie Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 53 |
| C07J63/008 | 39 |
| A61P35/00 | 35 |
| A61P9/10 | 31 |
| A61P9/00 | 28 |